Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Operating Expenses (2016 - 2026)

Updated

Spero Therapeutics' Operating Expenses was $9.93 million in Q2 2026, down 40.3% from $16.63 million a year earlier but up 27.3% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Operating Expenses (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Spero Therapeutics' Operating Expenses was $40.97 million through Jun 30, 2026, down 61.4% year-over-year; for FY2025, it came in at $60.49 million, down 50.1% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of -7.3% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $121.34 million in FY2024 (+47.4%), $82.3 million in FY2023 (-14.0%), $95.71 million in FY2022 (-9.9%) and $106.23 million in FY2021 (+20.1%).
  • Quarterly Operating Expenses has moved between $7.8 million (Q1 2026) and $36.77 million (Q4 2024) over five years.
  • Compared with a year earlier, Operating Expenses has declined for six straight quarters, with an average decline of 26.4% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q3 2023 (growth of 98.0%); the worst was Q4 2025 (a decline of 73.1%).
  • Per Business Quant data, SPRO's Operating Expenses in the three quarters before Q2 2026 was $7.8 million (Q1 2026), $9.89 million (Q4 2025) and $13.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 Spero Therapeutics 68.40 Mn -127.38 Mn - 9.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.93 Mn
Mar 31, 2026 7.80 Mn
Dec 31, 2025 9.89 Mn
Sep 30, 2025 13.36 Mn
Jun 30, 2025 16.63 Mn
Mar 31, 2025 20.61 Mn
Dec 31, 2024 36.77 Mn
Sep 30, 2024 32.06 Mn
Jun 30, 2024 29.26 Mn
Mar 31, 2024 23.25 Mn
Dec 31, 2023 22.99 Mn
Sep 30, 2023 27.41 Mn
Jun 30, 2023 15.61 Mn
Mar 31, 2023 16.30 Mn
Dec 31, 2022 21.52 Mn
Sep 30, 2022 13.84 Mn
Jun 30, 2022 28.07 Mn
Mar 31, 2022 32.28 Mn
Dec 31, 2021 30.25 Mn
Sep 30, 2021 25.59 Mn
API Access

Spero Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SPRO&period=max&api_key=YOUR_API_KEY